430
Views
35
CrossRef citations to date
0
Altmetric
Review

Advances in hepatitis E – II: Epidemiology, clinical manifestations, treatment and prevention

&
Pages 1065-1074 | Received 27 Apr 2016, Accepted 27 Apr 2016, Published online: 20 May 2016

References

  • Khuroo MS. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A,non-B type. Am J Med. 1980 Jun;68(6):818–824.
  • Viswanathan R. Infectious hepatitis in Delhi (1955–56): a critical study: epidemiology. Indian J Med Res. 1957;45(Suppl. 1):1–29.
  • Meng XJ, Purcell RH, Halbur PG, et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci USA. 1997 Sep 2;94(18):9860–9865.
  • Sonoda H, Abe M, Sugimoto T, et al. Prevalence of hepatitis E virus (HEV) Infection in wild boars and deer and genetic identification of a genotype 3 HEV from a boar in Japan. J Clin Microbiol. 2004 Nov;42(11):5371–5374.
  • Kwo PY, Schlauder GG, Carpenter HA, et al. Acute hepatitis E by a new isolate acquired in the United States. Mayo Clin Proc. 1997 Dec;72(12):1133–1136.
  • Schlauder GG, Dawson GJ, Erker JC, et al. The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United States. J Gen Virol. 1998 Mar;79(Pt 3):447–456.
  • Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008 Feb 21;358(8):811–817.
  • Aggarwal R, Goel A. Advances in hepatitis E – I: Virology, pathogenesis and diagnosis. Expert Rev Gastroenterol Hepatol. 2016;10. doi:10.1080/17474124.2016.1185362.
  • Aggarwal R. The global prevalence of hepatitis E virus infection and susceptibility: a systematic review. Geneva (Switzerland): World Health Organization; 2010. http://whqlibdoc.who.int/hq/2010/WHO_IVB_10.14_eng.pdf.
  • Aggarwal R, Jameel S. Hepatitis E. Hepatology. 2011 Dec;54(6):2218–2226.
  • Aggarwal R, Naik S. Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol. 2009 Sep;24(9):1484–1493.
  • Viswanathan R. Infectious hepatitis in Delhi (1955–56): A critical study: epidemiology. Indian J Med Res. 1957;45(Suppl 1):1–29.
  • Naik SR, Aggarwal R, Salunke PN, et al. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ. 1992;70(5):597–604.
  • Khuroo MS, Teli MR, Skidmore S, et al. Incidence and severity of viral hepatitis in pregnancy. Am J Med. 1981 Feb;70(2):252–255.
  • Aggarwal R, Naik SR. Hepatitis E: intrafamilial transmission versus waterborne spread. J Hepatol. 1994 Nov;21(5):718–723.
  • Somani SK, Aggarwal R, Naik SR, et al. A serological study of intrafamilial spread from patients with sporadic hepatitis E virus infection. J Viral Hepat. 2003 Nov;10(6):446–449.
  • Khuroo MS, Kamili S, Jameel S. Vertical transmission of hepatitis E virus. Lancet. 1995 Apr 22;345(8956):1025–1026.
  • Aggarwal R, Kini D, Sofat S, et al. Duration of viraemia and faecal viral excretion in acute hepatitis E. Lancet. 2000 Sep 23;356(9235):1081–1082.
  • Aggarwal R, Kamili S, Spelbring J, et al. Experimental studies on subclinical hepatitis E virus infection in cynomolgus macaques. J Infect Dis. 2001 Dec 1;184(11):1380–1385.
  • Shukla P, Chauhan UK, Naik S, et al. Hepatitis E virus infection among animals in northern India: an unlikely source of human disease. J Viral Hepat. 2007 May;14(5):310–317.
  • Arankalle VA, Chobe LP, Joshi MV, et al. Human and swine hepatitis E viruses from Western India belong to different genotypes. J Hepatol. 2002 Mar;36(3):417–425.
  • Meng XJ, Halbur PG, Haynes JS, et al. Experimental infection of pigs with the newly identified swine hepatitis E virus (swine HEV), but not with human strains of HEV. Arch Virol. 1998;143(7):1405–1415.
  • Dalton HR, Hunter JG, Bendall RP. Hepatitis E. Curr Opin Infect Dis. 2013 Oct;26(5):471–478.
  • Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet. 2012 Jun 30;379(9835):2477–2488.
  • Meng XJ, Halbur PG, Shapiro MS, et al. Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol. 1998 Dec;72(12):9714–9721.
  • Erker JC, Desai SM, Schlauder GG, et al. A hepatitis E virus variant from the United States: molecular characterization and transmission in cynomolgus macaques. J Gen Virol. 1999 Mar;80((Pt 3)(4)):681–690.
  • Tei S, Kitajima N, Takahashi K, et al. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet. 2003 Aug 2;362(9381):371–373.
  • Feagins AR, Opriessnig T, Guenette DK, et al. Detection and characterization of infectious Hepatitis E virus from commercial pig livers sold in local grocery stores in the USA. J Gen Virol. 2007 Mar;88(Pt 3):912–917.
  • Arankalle VA, Chobe LP. Hepatitis E virus: can it be transmitted parenterally? J Viral Hepat. 1999 Mar;6(2):161–164.
  • Khuroo MS, Kamili S, Yattoo GN. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol. 2004 Jul;19(7):778–784.
  • Arankalle VA, Chobe LP. Retrospective analysis of blood transfusion recipients: evidence for post-transfusion hepatitis E. Vox Sang. 2000;79(2):72–74.
  • Hewitt PE, Ijaz S, Brailsford SR, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet. 2014 Nov 15;384(9956):1766–1773.
  • Petrik J, Lozano M, Seed CR, et al. Hepatitis E. Vox Sang. 2016 Jan;110(1):93–103.
  • Nelson KE. Transmission of hepatitis E virus by transfusion: what is the risk? Transfusion. 2014 Jan;54(1):8–10.
  • Munjal S, Gupta N, Sharma RK, et al. Lack of persistent hepatitis E virus infection as a cause for unexplained transaminase elevation in renal transplant recipients in India. Indian J Gastroenterol. 2014 Nov;33(6):550–553.
  • Aggarwal R. Hepatitis E: historical, contemporary and future perspectives. J Gastroenterol Hepatol. 2011 Jan;26(Suppl 1):72–82.
  • Kmush B, Wierzba T, Krain L, et al. Epidemiology of hepatitis E in low- and middle-income countries of Asia and Africa. Semin Liver Dis. 2013 Feb;33(1):15–29.
  • Rein DB, Stevens GA, Theaker J, et al. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology. 2012 Apr;55(4):988–997.
  • Aggarwal R. Clinical presentation of hepatitis E. Virus Res. 2011 Oct;161(1):15–22.
  • Aggarwal R. Hepatitis E: clinical presentation in disease-endemic areas and diagnosis. Semin Liver Dis. 2013 Feb;33(1):30–40.
  • Pavio N, Mansuy JM. Hepatitis E in high-income countries. Curr Opin Infect Dis. 2010 Oct;23(5):521–527.
  • Bazerbachi F, Haffar S, Garg SK, et al. Extra-hepatic manifestations associated with hepatitis E virus infection: a comprehensive review of the literature. Gastroenterol Rep. 2016 Feb;4(1):1–15.
  • Cheung MC, Maguire J, Carey I, et al. Review of the neurological manifestations of hepatitis E infection. Ann Hepatol. 2012 Sep–Oct;11(5):618–622.
  • Kamar N, Izopet J, Cintas P, et al. Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am J Transplant. 2010 May;10(5):1321–1324.
  • Bhagat S, Wadhawan M, Sud R, et al. Hepatitis viruses causing pancreatitis and hepatitis: a case series and review of literature. Pancreas. 2008 May;36(4):424–427.
  • Kamar N, Weclawiak H, Guilbeau-Frugier C, et al. Hepatitis E virus and the kidney in solid-organ transplant patients. Transplantation. 2012 Mar 27;93(6):617–623.
  • Ali G, Kumar M, Bali SK, et al. Hepatitis E associated immune thrombocytopenia and membranous glomerulonephritis. Indian J Nephrol. 2001;11(2):70–72.
  • Singh NK, Gangappa M. Acute immune thrombocytopenia associated with hepatitis E in an adult. Am J Hematol. 2007 Oct;82(10):942–943.
  • Abid S, Khan AH. Severe hemolysis and renal failure in glucose-6-phosphate dehydrogenase deficient patients with hepatitis E. Am J Gastroenterol. 2002 Jun;97(6):1544–1547.
  • Thapa R, Biswas B, Mallick D. Henoch-Schönlein purpura triggered by acute hepatitis E virus infection. J Emerg Med. 2010 Aug;39(2):218–219.
  • Al-Shukri I, Davidson E, Tan A, et al. Rash and arthralgia caused by hepatitis E. Lancet. 2013 Nov 30;382(9907):1856.
  • Kumar A, Aggarwal R, Naik SR, et al. Hepatitis E virus is responsible for decompensation of chronic liver disease in an endemic region. Indian J Gastroenterol. 2004 Mar–Apr;23(2):59–62.
  • Kumar Acharya S, Kumar Sharma P, Singh R, et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol. 2007 Mar;46(3):387–394.
  • Bhatia V, Singhal A, Panda SK, et al. A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse? Hepatology. 2008 Nov;48(5):1577–1585.
  • Patra S, Kumar A, Trivedi SS, et al. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med. 2007 Jul 3;147(1):28–33.
  • Gurley ES, Hossain MJ, Paul RC, et al. Outbreak of hepatitis E in urban Bangladesh resulting in maternal and perinatal mortality. Clin Infect Dis. 2014 Sep 1;59(5):658–665.
  • Khuroo MS, Kamili S, Khuroo MS. Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers. J Viral Hepat. 2009 Jul;16(7):519–523.
  • Dalton HR, Bendall RP, Keane FE, et al. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med. 2009 Sep 3;361(10):1025–1027.
  • Ollier L, Tieulie N, Sanderson F, et al. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med. 2009 Mar 17;150(6):430–431.
  • Kamar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011 May;140(5):1481–1489.
  • Geng Y, Zhang H, Huang W, et al. Persistent hepatitis E virus genotype 4 infection in a child with acute lymphoblastic leukemia. Hepat Mon. 2014;14(1:e15618.
  • Geng Y, Zhao C, Huang W, et al. Detection and assessment of infectivity of hepatitis E virus in urine. J Hepatol. 2016 Jan;64(1):37–43.
  • Kamar N, Rostaing L, Izopet J. Hepatitis E virus infection in immunosuppressed patients: natural history and therapy. Semin Liver Dis. 2013 Feb;33(1):62–70.
  • Haagsma EB, Van Den Berg AP, Porte RJ, et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl. 2008 Apr;14(4):547–553.
  • Gerolami R, Borentain P, Raissouni F, et al. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol. 2011 Sep;52(1):60–62.
  • Goyal R, Kumar A, Panda SK, et al. Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report. Antivir Ther. 2012 Aug 16;17(6):1091–1096.
  • Kamar N, Izopet J, Tripon S, et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med. 2014 Mar 20;370(12):1111–1120.
  • Debing Y, Emerson SU, Wang Y, et al. Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon. Antimicrob Agents Chemother. 2014 Jan;58(1):267–273.
  • Paeshuyse J, Dallmeier K, Neyts J. Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action. Curr Opin Virol. 2011 Dec;1(6):590–598.
  • Kamar N, Lhomme S, Abravanel F, et al. An early viral response predicts the virological response to ribavirin in hepatitis E virus organ transplant patients. Transplantation. 2015 Oct;99(10):2124–2131.
  • Debing Y, Gisa A, Dallmeier K, et al. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients. Gastroenterology. 2014;147(5):1008–11e7. quiz e15-6
  • Dao Thi VL, Debing Y, Wu X, et al. Sofosbuvir inhibits hepatitis E virus replication in vitro and results in an additive effect when combined with ribavirin. Gastroenterology. 2016 Jan;150(1):82–85.e4.
  • Kamili S. Toward the development of a hepatitis E vaccine. Virus Res. 2011 Oct;161(1):93–100.
  • Shrestha MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med. 2007 Mar 1;356(9):895–903.
  • Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet. 2010 Sep 11;376(9744):895–902.
  • Gao S, Li D, Liu Y, et al. Oral immunization with recombinant hepatitis E virus antigen displayed on the Lactococcus lactis surface enhances ORF2-specific mucosal and systemic immune responses in mice. Int Immunopharmacol. 2015 Jan;24(1):140–145.
  • Zhang J, Zhang XF, Huang SJ, et al. Long-term efficacy of a hepatitis E vaccine. N Engl J Med. 2015 Mar 5;372(10):914–922.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.